Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease. Research found that beta-2 microglobulin levels were significantly elevated in postmenopausal women with CHD, and insulin-like growth factor binding protein 4 was strongly associated with stroke.